Insider · CIK 0001690133
Philip P. Breitfeld
director
Files at CSBR (CHAMPIONS ONCOLOGY, INC.). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 25, 2025 | CSBR CHAMPIONS ONCOLOGY, INC. | JOther Common Stock | -4,150 | $0.00 | $0 | 5,717 | Apr 2, 2025 |
| Nov 12, 2024 | CSBR CHAMPIONS ONCOLOGY, INC. | AGrant or award Option to purchase Common Stockderivative | +18,715 | $4.64 | $87k | 18,715 | Nov 18, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.